Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Directed search for thrombomodulin gene mutations

H Ireland1, K Kyriakoulis, G Kunz

  • 1Department of Haematology, Charing Cross and Westminster Medical School, London.

Haemostasis
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stop and Go: Barriers and Facilitators to Care Home Research.

The Journal of frailty & aging·2023
Same author

Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke.

Journal of thrombosis and haemostasis : JTH·2018
Same author

ADAMTS-13 and von Willebrand factor: a dynamic duo.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.

Journal of internal medicine·2017
Same author

Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study.

Breast cancer research and treatment·2017
Same journal

Thrombosis and Haemostasis Issues in Cancer. International Conference. Bergamo, Italy, 2-4 November 2001. Lectures and abstracts.

Haemostasis·2002
Same journal

Biochemistry of cancer procoagulant.

Haemostasis·2002
Same journal

Management of thromboembolic disease in cancer patients.

Haemostasis·2002
Same journal

An overview of thromboprophylaxis in malignancy.

Haemostasis·2002
Same journal

Platelets cross-talk with tumor cells.

Haemostasis·2002
Same journal

Properties and function of heparanase in cancer metastasis and angiogenesis.

Haemostasis·2002
See all related articles

Investigating thrombomodulin gene mutations is crucial for understanding thrombosis. This study designs a strategy to detect thrombomodulin gene mutations in patients with arterial and venous thrombosis.

Area of Science:

  • Biochemistry
  • Genetics
  • Vascular Biology

Background:

  • Thrombomodulin is a key thrombin receptor on vascular endothelium.
  • It shifts thrombin's function from procoagulant to anticoagulant by activating protein C.
  • Gene mutations in other anticoagulant proteins (Protein C, S, Factor V) are linked to venous thromboembolism, but thrombomodulin gene mutations are less studied.

Purpose of the Study:

  • To design and evaluate a strategy for investigating thrombomodulin gene mutations.
  • To assess the role of thrombomodulin gene mutations in both arterial and venous thrombosis.

Main Methods:

  • Development of a specific strategy to screen for thrombomodulin gene mutations.
  • Evaluation of this strategy in the context of arterial and venous thrombosis cases.

Related Experiment Videos

Main Results:

  • The study presents a novel strategy for investigating thrombomodulin gene mutations.
  • This strategy is designed for application in patients experiencing arterial and venous thrombosis.

Conclusions:

  • A systematic approach to investigate thrombomodulin gene mutations has been established.
  • This strategy aims to improve the understanding of thrombomodulin's role in thrombosis pathogenesis.